WRIGHT MEDICAL PUBLIC STATEMENT ON COVID-19
The health and safety of our employees, customers and communities is our priority. We have an active COVID-19 task force that is assessing any potential impact to our business. We are currently operating normally, and we have enacted several measures to protect the health and safety of our employees and to protect the continuity of supply to our customers. We will continue to vigilantly monitor the situation and implement additional actions as needed.
This is an unprecedented time for everyone, and the situation is changing daily. We are committed to maintaining our business operations and communicating with our customers if their service or products from Wright are impacted by the COVID-19 situation. We will keep you updated as events warrant.
Given that this is a rapidly evolving topic, Wright employees, customers and stakeholders should regularly monitor the Centers for Disease Control and Prevention website and similar websites for local authorities for any updated guidance as the situation evolves.
Thank you for your continued trust in Wright.
Wrightについて
Wright Medical Group N.V.は四肢とバイオ医薬品に特化し、グローバルに事業を展開する医療機器の会社です。私たちはイノベーティブで付加価値の高いソリューションをご提供することにより、世界中の患者さんの生活の質の向上を目指します。整形外科の分野で最も急成長を遂げる3つの分野である、上肢（肩、肘、手首、手）、下肢（足、足首）の外科的ソリューション、およびバイオ医薬品市場において、当社はその第一人者と認識されています。
医師を検索する
投資家情報
Data provided by Nasdaq. Minimum 15 minutes delayed.
